Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Osprey Medical, Inc
The purpose of this observational study is to evaluate the amount of contrast media saved using DyeVert Plus in coronary angiographic and/or interventional procedures performed with manual injection and evaluate the impact of predetermined thresholds and real-time monitoring.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Scheduled to undergo CAG and/or PCI
Baseline estimated glomerular filtration rate (eGFR) of ≥20 and ≤60 mL/ min/1.73 m2
You may not be if
Acute ST-elevation myocardial infarction or known coronary artery fistulas
Body mass index (BMI) \>40
Currently pregnant
Undergoing a chronic total occlusion procedure or optical coherence tomography analysis
Planning to undergo transcatheter aortic valve replacement within 72 hr of the index procedure
A condition known to require large volumes of contrast (\>10 mL) for each injection
Clareo Health | DyeVert™ Plus Contrast Reduction System Multicenter Observational Study
